Research Article

Amelioration of ischemic lung injury with pentoxifylline

Volume: 5 Number: 1 January 1, 1992
  • M.A. Bedirhan
  • İ. Okar
  • R. Kayapinar
  • B. Karamanlioglu
  • T. Demirel
  • S. Canbaz
  • A. Karadeniz
EN

Amelioration of ischemic lung injury with pentoxifylline

Abstract

The optimum method for lung preservation in preparation for transplantation remains unresolved. In this study we evaluated the effectiveness of Pentoxifylline to find an ideal perfusate to increase the success of preservation in a model which consisted of exposing the left lung of each experimental dog to normothermic ischemia after clamping the pulmonary artery, vein and bronchus. After ischemic periods of three hours, pulmonary circulation were reestablished. The left lung of dogs was perfused with Euro-Collins solution alone in group A (n=2) and with Euro-Collins solution containing 2500 ng/ml Pentoxifylline in group B (n=2). The mean ischemic time was three hours in both groups. Specimens for light and electronmicroscopic investigations taken seven days after the initial operation, showed that addition of Pentoxifylline to the perfusate appears to be beneficial in the preservation of allograft patency in organ protection.

Keywords

References

  1. Patterson QA, Cooper JD. Status of lung transplantation. Surg Clin north Am 1988; 68:545

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

M.A. Bedirhan This is me
Türkiye

İ. Okar This is me
Türkiye

R. Kayapinar This is me
Türkiye

B. Karamanlioglu This is me
Türkiye

T. Demirel This is me
Türkiye

S. Canbaz This is me
Türkiye

A. Karadeniz This is me
Türkiye

Publication Date

January 1, 1992

Submission Date

October 13, 2016

Acceptance Date

October 1, 1991

Published in Issue

Year 1992 Volume: 5 Number: 1

APA
Bedirhan, M., Okar, İ., Kayapinar, R., Karamanlioglu, B., Demirel, T., Canbaz, S., & Karadeniz, A. (1992). Amelioration of ischemic lung injury with pentoxifylline. Marmara Medical Journal, 5(1), 21-26. https://izlik.org/JA95FT87GK
AMA
1.Bedirhan M, Okar İ, Kayapinar R, et al. Amelioration of ischemic lung injury with pentoxifylline. Marmara Med J. 1992;5(1):21-26. https://izlik.org/JA95FT87GK
Chicago
Bedirhan, M.A., İ. Okar, R. Kayapinar, et al. 1992. “Amelioration of Ischemic Lung Injury With Pentoxifylline”. Marmara Medical Journal 5 (1): 21-26. https://izlik.org/JA95FT87GK.
EndNote
Bedirhan M, Okar İ, Kayapinar R, Karamanlioglu B, Demirel T, Canbaz S, Karadeniz A (January 1, 1992) Amelioration of ischemic lung injury with pentoxifylline. Marmara Medical Journal 5 1 21–26.
IEEE
[1]M. Bedirhan et al., “Amelioration of ischemic lung injury with pentoxifylline”, Marmara Med J, vol. 5, no. 1, pp. 21–26, Jan. 1992, [Online]. Available: https://izlik.org/JA95FT87GK
ISNAD
Bedirhan, M.A. - Okar, İ. - Kayapinar, R. - Karamanlioglu, B. - Demirel, T. - Canbaz, S. - Karadeniz, A. “Amelioration of Ischemic Lung Injury With Pentoxifylline”. Marmara Medical Journal 5/1 (January 1, 1992): 21-26. https://izlik.org/JA95FT87GK.
JAMA
1.Bedirhan M, Okar İ, Kayapinar R, Karamanlioglu B, Demirel T, Canbaz S, Karadeniz A. Amelioration of ischemic lung injury with pentoxifylline. Marmara Med J. 1992;5:21–26.
MLA
Bedirhan, M.A., et al. “Amelioration of Ischemic Lung Injury With Pentoxifylline”. Marmara Medical Journal, vol. 5, no. 1, Jan. 1992, pp. 21-26, https://izlik.org/JA95FT87GK.
Vancouver
1.M.A. Bedirhan, İ. Okar, R. Kayapinar, B. Karamanlioglu, T. Demirel, S. Canbaz, A. Karadeniz. Amelioration of ischemic lung injury with pentoxifylline. Marmara Med J [Internet]. 1992 Jan. 1;5(1):21-6. Available from: https://izlik.org/JA95FT87GK